Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yinfeng Biological Group
Jinan, Shandong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Yinfeng Biological Group operates the largest professional human cell bank in China, with ongoing clinical trials in stem cell therapies (up to Phase 1/2 for decompensated cirrhosis, others in preclinical), CAR-T programs for hematological malignancies, and additional cell-based and gene therapy research targeting immune, hematologic, liver, and joint indications.
- Therapeutic areas
- ImmunologyNephrologyRheumatologyGastroenterologyOncology
- Modalities
- Stem cell therapyCAR-T cell therapyCell therapyGene therapyMesenchymal stem cell therapyAdipose-derived stem cell therapy
- Industry
- Biotech
02
Partnerships
Zhejiang Hengdian APELOA/APELOA Pharmaceutical (manufacturing/quality collaboration)
Beyond the preview
Go deeper on Yinfeng Biological Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yinfeng Biological Group.